Agnieszka J. U.
- Country
- Poland
- Department
- N/A
Research Overview
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of GS-0151 in Patients With Rheumatoid Arthritis: A Clinical Trial
- A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Data & Insights
Has run more than one trial at 573 of 1048 partner sites.
Specializations
Dermatological Conditions
The investigator specializes in treating complex skin disorders, with particular emphasis on moderate to severe plaque psoriasis and chronic spontaneous urticaria.
- Inflammatory Skin Disorders
- Autoimmune Skin Conditions
- Chronic Urticaria Management
Their clinical expertise extends to evaluating novel therapeutic approaches for patients with treatment-resistant dermatological conditions.
Therapeutic Focus
The investigator concentrates on advancing treatment options for patients with chronic skin conditions, exploring innovative therapeutic agents for managing persistent symptoms.
- Long-term Disease Management
- Novel Treatment Evaluation
- Clinical Response Assessment
Their work involves evaluating the safety and efficacy of new therapeutic compounds in dermatological applications.
Clinical Expertise
The investigator's practice focuses on treating patients with treatment-resistant skin disorders, particularly those requiring systematic therapeutic approaches.
- Disease Activity Monitoring
- Treatment Response Evaluation
- Long-term Safety Assessment
Their clinical work emphasizes comprehensive patient care in chronic dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.